BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15955774)

  • 1. Re: 'Avoidance hierarchies and preferences for anticoagulation--semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin'.
    Choudhury A; Chowdhury SR; Connolly DL
    Age Ageing; 2005 Jul; 34(4):416; author reply 416-7. PubMed ID: 15955774
    [No Abstract]   [Full Text] [Related]  

  • 2. Avoidance hierarchies and preferences for anticoagulation--semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin.
    Fuller R; Dudley N; Blacktop J
    Age Ageing; 2004 Nov; 33(6):608-11. PubMed ID: 15385273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 4. [The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention].
    Neundörfer B
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):383-4. PubMed ID: 18604771
    [No Abstract]   [Full Text] [Related]  

  • 5. Which patients with atrial fibrillation do not need anticoagulation therapy with warfarin?
    Guthmann RA
    Am Fam Physician; 2004 Sep; 70(5):917-8. PubMed ID: 15368730
    [No Abstract]   [Full Text] [Related]  

  • 6. Atrial fibrillation and stroke prevention.
    Kakar P; Lip GY
    Expert Rev Neurother; 2006 Oct; 6(10):1523-30. PubMed ID: 17078791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.
    Lane D; Lip GY
    Age Ageing; 2005 Jan; 34(1):1-3. PubMed ID: 15591476
    [No Abstract]   [Full Text] [Related]  

  • 8. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 9. Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation.
    Hammwöhner M; Goette A
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):18-27. PubMed ID: 18594479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustainability and impact of warfarin compliance for atrial fibrillation.
    Kuo S; Burrill J
    Med Health R I; 2007 Dec; 90(12):378-80. PubMed ID: 18314828
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulation control in atrial fibrillation: optimizing risks and benefits.
    Alsheikh-Ali AA; Estes NA
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):72-3. PubMed ID: 20031792
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-intensity anticoagulation for stroke prevention in elderly patients with atrial fibrillation: efficacy and safety in actual clinical practice.
    Ono A; Fujita T
    J Clin Neurosci; 2005 Nov; 12(8):891-4. PubMed ID: 16271478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulation and stroke in atrial fibrillation.
    Epstein EF; Natarajan I
    N Engl J Med; 2003 Dec; 349(24):2360-1; author reply 2360-1. PubMed ID: 14674042
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of warfarin and aspirin for stroke prevention in elderly patients with atrial fibrillation].
    Han W; Shen DT; Wang YM
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):851-2, 855. PubMed ID: 16793618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation in the octogenarian with atrial fibrillation.
    Kapoor M; McNicoll L
    Med Health R I; 2009 Apr; 92(4):152-4. PubMed ID: 19452760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation.
    Burkiewicz JS
    Pharmacotherapy; 2005 Aug; 25(8):1062-7. PubMed ID: 16207096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does long-term warfarin affect the quality of life of older people?
    Das AK; Willcoxson P; Corrado OJ
    Age Ageing; 2005 May; 34(3):312-3. PubMed ID: 15863424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.